Novo Nordisk's Wegovy improves kidney health in patients with obesity (NYSE:NVO)
hapabapa/iStock Editorial via Getty Images Novo Nordisk's (NVO) anti-obesity therapy Wegovy reduced kidney-related adverse events by 22% in overweight and ...
Tag: obesity
JP Morgan event in focus amid biotech M&A and obesity frenzy
Lina Moiseienko/iStock Publishing via Getty Images Recent momentum in biotech deals, growing interest in weight-loss drugs and the popularity of ...
